Ureteroscope is a medical device, used for examining the urinary tract and the technique is called ureteroscopy. It has a similar function to a cystoscope, but it is longer and thinner than cystoscope. This device has illuminating light and lense that capture images of urinary tract organs and detect tumors and calculi. Moreover, this device is useful in detecting stones in the ureter and is also beneficial for the removal of kidney stones. Ureteroscopy procedure has high accuracy and less complication than conventional devices such as percutaneous nephrolithotripsy (PCNL) and extracorporeal shock wave lithotripsy (ESWL).
Download the Sample copy of Report with Table of Contents and Figures @ https://www.coherentmarketinsights.com/insight/request-pdf/1603
Growing approvals and launches of new ureteroscopes devices are projected to be a major factor for the growth of the global ureteroscopes market. For instance, in 2016, Boston Scientific Corporation launched its new LithoVue single-use digital flexible ureteroscope in the U.S. and Europe market. LithoVue is used in the minimally invasive diagnosis and treatment of kidney stones and other conditions related to kidney, ureter, and bladder.
Furthermore, the growing prevalence of kidney stones is projected to increase demand for ureteroscopes ultimately fuelling market growth. For instance, according to the data published by the National Kidney Foundation in 2016, globally, over half a billion people suffer from kidney stones annually. According to data published by the National Institute of Health, in 2016, globally, the total prevalence of chronic kidney disease is around 14.0% of the general population.
Moreover, the growing prevalence of kidney stones also increases with increasing age. According to the data published in National Center for Biotechnology Information, in 2017, in Mainland China, the prevalence of kidney stones was 5.96% in the people aged between 30-39 years, while the prevalence was around 9.68% in people above 60 years of age. Therefore, the growing geriatric population is also projected to demand ureteroscopes and fuel market growth in the near future. For instance, according to the United Nations, Economic and Social Commission for Asia and the Pacific (ESCAP) 2016, around 547 million people were aged above 60 years in the Asia Pacific and the number is projected to reach around 1.3 billion by 2050.
North America is expected to hold the dominant position in the global ureteroscopes market, owing to the presence of major players in the region and high success rates of ureteroscopy. For instance, according to data published by Department of Urology, New York Medical College, in 2016, after a single procedure, around 37% of patients who had undergone flexible ureteroscopy were stone free as compared to only 21% of the patients who were treated with Extracorporeal Shock Wave Lithotripsy (ESWL). Moreover, Boston Scientific Corporation and Stryker Corporation are the two U.S.-based major players in this market. Furthermore, the growing prevalence of kidney stones in the U.S. is also projected to propel the demand for ureteroscopes, which in turn is driving the market growth in North America. For instance, according to data published in National Center for Biotechnology Information, in 2014, according to survey done by National Health and Nutrition Examination in 2012, around 10.6% of men and 7.1% of women in the U.S. are affected from renal stone disease and there is a rapid increase in prevalence of urinary tract stone disease. The Asia Pacific is expected to exhibit significant growth in the global ureteroscopes market, and this can be attributed to the increasing incidence of kidney stone disease in the region and China. For instance, according to data published in the National Center for Biotechnology Information in 2017, the prevalence of kidney stones in Mainland China was estimated to be around 10.34% in males and 6.62% in females.
Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/ureteroscopes-market-1603
On the other hand, the high cost associated with the ureteroscopy procedure is projected to be a major restraint for the growth of the global ureteroscopes market. The average cost of ureteroscopy in the U.S. can go up to around US$ 3,000. Such high-cost procedures are not easily affordable by everyone and hence it restrains the market growth.
Key players operating in the ureteroscopes market include Boston Scientific Corporation, Olympus Corporation, Stryker Corporation, KARL STORZ SE & Co. KG, Richard Wolf GmbH, PENTAX Medical, Elmed Electronics & Medical Industry & Trade Inc., AED.MD, SCHÖLLY FIBEROPTIC GMBH, OPCOM Inc., Prosurg, Inc., SOPRO-COMEG GmbH, and others.
The global ureteroscopes market is segmented based on product type, application, end-user, and region:
By Product Type-
- Flexible Ureteroscopes
- Fiberoptic Ureteroscopes
- Digital Ureteroscopes
- Semi-rigid Ureteroscopes
- Rigid Ureteroscopes
- Kidney Cancer
- Ureteral Stinctures
- Specialty Clinics
- Ambulatory Surgical Centers
- Diagnostic Imaging Centers
- North America
- Latin America
- Asia Pacific
- Middle East
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Name: Mr. Raj Shah
Phone: US +12067016702 / UK +4402081334027